Abstract
It has been observed that the overproduction of Nitric Oxide (NO) causes disfunction of several organs and affects lactate level. Hence, attempts have been made to design and develop potent inhibitors for Nitric Oxide Synthases (NOSs), the enzymes which are responsible for its production. NOSs exist mainly in three different isoforms: neuronal, inducible, and endothelial, designated as nNOS, iNOS, and eNOS, respectively. For design and development of potent NOS inhibitors against all the 3 isoforms several Quantitative Structure-Activity Relationship (QSAR) studies were made. This article compiles comprehensively all such studies and discusses critically their outcome. For the inhibitors of all isoforms, some pharmacophore models have been developed in which commonly at least one H-bond donor, one H-bond acceptor, one hydrophobic group, and in some positively charged moieties have been found to be essential. Consistent to these pharmacophores, 2D and 3D QSAR studies have pointed out that all NOS inhibitors undergo H-bond, hydrophobic, electronic and steric interactions with the receptors.
Keywords: Nitric oxide synthase inhibitors, quantitative structure-activity relationships.
Current Enzyme Inhibition
Title:Quantitative Structure-Activity Relationship Studies on Nitric Oxide Synthase Inhibitors
Volume: 12 Issue: 1
Author(s): Satya P. Gupta, Harish Kumar and Basheerulla Shaik
Affiliation:
Keywords: Nitric oxide synthase inhibitors, quantitative structure-activity relationships.
Abstract: It has been observed that the overproduction of Nitric Oxide (NO) causes disfunction of several organs and affects lactate level. Hence, attempts have been made to design and develop potent inhibitors for Nitric Oxide Synthases (NOSs), the enzymes which are responsible for its production. NOSs exist mainly in three different isoforms: neuronal, inducible, and endothelial, designated as nNOS, iNOS, and eNOS, respectively. For design and development of potent NOS inhibitors against all the 3 isoforms several Quantitative Structure-Activity Relationship (QSAR) studies were made. This article compiles comprehensively all such studies and discusses critically their outcome. For the inhibitors of all isoforms, some pharmacophore models have been developed in which commonly at least one H-bond donor, one H-bond acceptor, one hydrophobic group, and in some positively charged moieties have been found to be essential. Consistent to these pharmacophores, 2D and 3D QSAR studies have pointed out that all NOS inhibitors undergo H-bond, hydrophobic, electronic and steric interactions with the receptors.
Export Options
About this article
Cite this article as:
P. Gupta Satya, Kumar Harish and Shaik Basheerulla, Quantitative Structure-Activity Relationship Studies on Nitric Oxide Synthase Inhibitors, Current Enzyme Inhibition 2016; 12 (1) . https://dx.doi.org/10.2174/1573408012666151126185958
DOI https://dx.doi.org/10.2174/1573408012666151126185958 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry Cadmium as an Endocrine Disruptor in the Reproductive System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Current Organic Chemistry Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine Pregnancy-Specific β1-Glycoproteins: Combined Biomarker Roles, Structure/Function Relationships and Implications for Drug Design
Current Medicinal Chemistry Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Glycomics and Mass Spectrometry
Current Pharmaceutical Design Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
Current Pharmaceutical Design Steroid Regulation of Drug-Metabolizing Cytochromes P450
Current Drug Metabolism Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review
Mini-Reviews in Medicinal Chemistry miR-27b-3p is Highly Expressed in Serum of Patients with Preeclampsia and has Clinical Significance
Endocrine, Metabolic & Immune Disorders - Drug Targets Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology Placental Drug Transporters
Current Drug Metabolism There is a Link Between Erectile Dysfunction and Heart Failure: It could be Inflammation
Current Drug Targets Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Current Medicinal Chemistry